Wednesday's HotCopper trends: Race RC220 doses, West Mits Qala study | July 23
Race Oncology (ASX:RAC) has captured the most attention on the HotCopper forums today after successfully @ and safely @ dosing its first patient with RC220 and RC220 in combination with doxorubicin.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines ...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
AAQ | realistic value | 12/04/13 | 6 | 4.4K | |||
|
|||||||
AAQ | set fair on a minuscule market cap | 21/03/13 | 18 | 6.5K | |||
|
|||||||
AAQ | Ann: Change of Company Name and Consolidation Tim | 06/02/13 | 0 | 1.0K | |||
|
|||||||
AAQ | Ann: Final Director's Interest Notices | 05/02/13 | 0 | 696 | |||
|
|||||||
AAQ | Ann: Initial Director's Interest Notices | 05/02/13 | 0 | 697 | |||
|
|||||||
AAQ | Ann: AAQ Holdings Update | 05/02/13 | 0 | 1.0K | |||
|
|||||||
AAQ | Ann: Results of Adjourned Annual General Meeting | 03/02/13 | 1 | 1.6K | |||
|
|||||||
AAQ | Ann: December 2012 Quarterly Appendix 4C | 31/01/13 | 0 | 788 | |||
|
See All Discussions